ESLOF
Price
$363.68
Change
+$5.92 (+1.65%)
Updated
Dec 3 closing price
Capitalization
165.5B
Intraday BUY SELL Signals
MASS
Price
$6.65
Change
+$0.43 (+6.91%)
Updated
Dec 4, 04:59 PM (EDT)
Capitalization
225.12M
96 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ESLOF vs MASS

Header iconESLOF vs MASS Comparison
Open Charts ESLOF vs MASSBanner chart's image
EssilorLuxottica
Price$363.68
Change+$5.92 (+1.65%)
Volume$3.17K
Capitalization165.5B
908 Devices
Price$6.65
Change+$0.43 (+6.91%)
Volume$10.74K
Capitalization225.12M
ESLOF vs MASS Comparison Chart in %
ESLOF
Daily Signal:
Gain/Loss:
MASS
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ESLOF vs. MASS commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ESLOF is a StrongBuy and MASS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 05, 2025
Stock price -- (ESLOF: $363.67 vs. MASS: $6.22)
Brand notoriety: ESLOF and MASS are both not notable
ESLOF represents the Pharmaceuticals: Other, while MASS is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: ESLOF: 244% vs. MASS: 100%
Market capitalization -- ESLOF: $165.5B vs. MASS: $225.12M
ESLOF [@Pharmaceuticals: Other] is valued at $165.5B. MASS’s [@Medical/Nursing Services] market capitalization is $225.12M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $201.96B to $0. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $217.86B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.95B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.7B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ESLOF’s FA Score shows that 2 FA rating(s) are green whileMASS’s FA Score has 0 green FA rating(s).

  • ESLOF’s FA Score: 2 green, 3 red.
  • MASS’s FA Score: 0 green, 5 red.
According to our system of comparison, ESLOF is a better buy in the long-term than MASS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ESLOF’s TA Score shows that 3 TA indicator(s) are bullish while MASS’s TA Score has 5 bullish TA indicator(s).

  • ESLOF’s TA Score: 3 bullish, 4 bearish.
  • MASS’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both ESLOF and MASS are a good buy in the short-term.

Price Growth

ESLOF (@Pharmaceuticals: Other) experienced а +0.76% price change this week, while MASS (@Medical/Nursing Services) price change was -2.96% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.46%. For the same industry, the average monthly price growth was +7.98%, and the average quarterly price growth was +3.65%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +0.72%. For the same industry, the average monthly price growth was +2.19%, and the average quarterly price growth was +8.42%.

Reported Earning Dates

MASS is expected to report earnings on Mar 10, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (+0.46% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical/Nursing Services (+0.72% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ESLOF($165B) has a higher market cap than MASS($225M). MASS YTD gains are higher at: 182.727 vs. ESLOF (51.374). ESLOF has higher annual earnings (EBITDA): 6.71B vs. MASS (-68.12M). ESLOF has more cash in the bank: 3.16B vs. MASS (119M). MASS has less debt than ESLOF: MASS (4.43M) vs ESLOF (14B). ESLOF has higher revenues than MASS: ESLOF (27.2B) vs MASS (65.6M).
ESLOFMASSESLOF / MASS
Capitalization165B225M73,333%
EBITDA6.71B-68.12M-9,843%
Gain YTD51.374182.72728%
P/E Ratio60.73N/A-
Revenue27.2B65.6M41,463%
Total Cash3.16B119M2,655%
Total Debt14B4.43M315,956%
FUNDAMENTALS RATINGS
ESLOF: Fundamental Ratings
ESLOF
OUTLOOK RATING
1..100
68
VALUATION
overvalued / fair valued / undervalued
1..100
37
Fair valued
PROFIT vs RISK RATING
1..100
13
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
43
P/E GROWTH RATING
1..100
16
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ESLOFMASS
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
60%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
43%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
66%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
52%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 7 days ago
65%
Bullish Trend 10 days ago
79%
Declines
ODDS (%)
Bearish Trend 11 days ago
53%
Bearish Trend 7 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
53%
Bullish Trend 2 days ago
81%
Aroon
ODDS (%)
Bearish Trend 2 days ago
47%
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
ESLOF
Daily Signal:
Gain/Loss:
MASS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATOS0.740.04
+5.48%
Atossa Therapeutics
APPS4.910.13
+2.72%
Digital Turbine
PKX53.210.02
+0.04%
POSCO Holdings
KSS22.97-1.74
-7.04%
Kohls Corp
SYNX0.87-0.12
-11.82%
Silynxcom Ltd

ESLOF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ESLOF has been loosely correlated with ESLOY. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if ESLOF jumps, then ESLOY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ESLOF
1D Price
Change %
ESLOF100%
+1.66%
ESLOY - ESLOF
58%
Loosely correlated
+0.80%
SAUHF - ESLOF
39%
Loosely correlated
N/A
SMMNY - ESLOF
32%
Poorly correlated
-0.44%
NVCR - ESLOF
27%
Poorly correlated
+8.15%
MASS - ESLOF
24%
Poorly correlated
+2.13%
More

MASS and

Correlation & Price change

A.I.dvisor indicates that over the last year, MASS has been loosely correlated with CTKB. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if MASS jumps, then CTKB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MASS
1D Price
Change %
MASS100%
+2.13%
CTKB - MASS
40%
Loosely correlated
-0.56%
TWST - MASS
35%
Loosely correlated
+4.95%
SONVY - MASS
31%
Poorly correlated
-0.96%
CERS - MASS
31%
Poorly correlated
+6.42%
XAIR - MASS
30%
Poorly correlated
-4.39%
More